Erwinia Patents (Class 435/847)
  • Glucocorticoid sparing factor and process for the production of the same
    Patent number: 4278593
    Abstract: A glucocorticoid sparing factor (GSF) which amplifies liver enzyme induction which is caused in glucocorticoid and a process for the production of GSF are disclosed. GSF can be isolated from the culture broth of a microorganism of the Family Enterobacteriaceae.
    Type: Grant
    Filed: January 2, 1980
    Date of Patent: July 14, 1981
    Inventor: Nobuhiko Katsunuma
  • Microbiologic conversion of L-galactonate into 2-Keto L-galactonate
    Patent number: 4246348
    Abstract: A metabolic conversion of L-galactonic acid into 2-Keto-L-galactonic acid by cultivating a microorganism in the presence of an L-galactonate. This reaction is an important step in synthesis of Vitamin C from substances that can be obtained from pectin.
    Type: Grant
    Filed: October 23, 1978
    Date of Patent: January 20, 1981
    Assignee: Novo Laboratories, Inc.
    Inventors: Raymond P. Lanzilotta, Michael K. Weibel
  • Antibiotic BN-200 substance and process for production thereof
    Patent number: 4169889
    Abstract: An antibiotic BN-200 substance produced by cultivating a BN-200 substance strain of the genus Erwinia and a process for producing the BN-200 substance.
    Type: Grant
    Filed: October 4, 1978
    Date of Patent: October 2, 1979
    Assignee: Meiji Seika Kaisha, Ltd.
    Inventors: Shoichi Amano, Shinji Miyadoh, Mitsugu Itoh, Norio Ezaki, Eiichi Akita, Yujiro Yamada